Product NDC: | 60505-0578 |
Proprietary Name: | AZELASTINE HYDROCHLORIDE |
Non Proprietary Name: | AZELASTINE HYDROCHLORIDE |
Active Ingredient(s): | .5 mg/mL & nbsp; AZELASTINE HYDROCHLORIDE |
Administration Route(s): | INTRAOCULAR |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-0578 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078621 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091201 |
Package NDC: | 60505-0578-4 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (60505-0578-4) > 6 mL in 1 BOTTLE, PLASTIC |
NDC Code | 60505-0578-4 |
Proprietary Name | AZELASTINE HYDROCHLORIDE |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (60505-0578-4) > 6 mL in 1 BOTTLE, PLASTIC |
Product NDC | 60505-0578 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AZELASTINE HYDROCHLORIDE |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | INTRAOCULAR |
Start Marketing Date | 20091201 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | AZELASTINE HYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |